SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-253804
Filing Date
2023-10-11
Accepted
2023-10-11 06:05:56
Documents
7
Period of Report
2023-10-11

Document Format Files

Seq Description Document Type Size
1 6-K d866405d6k.htm 6-K 8714
2 EX-99.1 d866405dex991.htm EX-99.1 17446
3 EX-99.2 d866405dex992.htm EX-99.2 23284
4 GRAPHIC g866405dsp4.jpg GRAPHIC 2200
5 GRAPHIC g866405g1010190001642.jpg GRAPHIC 2601
6 GRAPHIC g866405g1010190809440.jpg GRAPHIC 2601
7 GRAPHIC g866405g38z08.jpg GRAPHIC 3951
  Complete submission text file 0001193125-23-253804.txt   66847
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 231319369
SIC: 2834 Pharmaceutical Preparations